There appears to be limited evidence supporting the use of epidural steroid injections for certain types of chronic lower ...

Last year, the American Academy of Ophthalmology recommended that patients experiencing vision problems while taking semaglutide stop using the drug and consult a physician.

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

New danger? Popular weight loss drugs and diabetes medications may trigger permanent eye damage! New study raises serious ...

The American Academy of Neurology (AAN) has developed a new systematic review to summarize for neurologists and other ...

The case for GLP-1 drugs like Ozempic possibly causing blindness is building. A new paper out this week describes several ...

The “Check Before You Inject” ad goes on to note that some vials of compounded semaglutide “have been found to contain ...

A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...

A new study suggests popular weight-loss drugs like Ozempic and Zepbound may be linked to rare eye conditions that could ...